BR0016168A - Combinações terapêuticas de (s)-2-(benzilaminometil)-2,3,8,9tetrahidro-7h-1,4-dioxi no[2,3 -e]indol-8-ona e neurolépticos para o tratamento ou prevenção de distúrbios psicóticos - Google Patents

Combinações terapêuticas de (s)-2-(benzilaminometil)-2,3,8,9tetrahidro-7h-1,4-dioxi no[2,3 -e]indol-8-ona e neurolépticos para o tratamento ou prevenção de distúrbios psicóticos

Info

Publication number
BR0016168A
BR0016168A BR0016168-3A BR0016168A BR0016168A BR 0016168 A BR0016168 A BR 0016168A BR 0016168 A BR0016168 A BR 0016168A BR 0016168 A BR0016168 A BR 0016168A
Authority
BR
Brazil
Prior art keywords
prevention
treatment
neuroleptics
therapeutic combinations
benzylaminomethyl
Prior art date
Application number
BR0016168-3A
Other languages
English (en)
Portuguese (pt)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR0016168A publication Critical patent/BR0016168A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR0016168-3A 1999-12-10 2000-12-07 Combinações terapêuticas de (s)-2-(benzilaminometil)-2,3,8,9tetrahidro-7h-1,4-dioxi no[2,3 -e]indol-8-ona e neurolépticos para o tratamento ou prevenção de distúrbios psicóticos BR0016168A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45860799A 1999-12-10 1999-12-10
PCT/US2000/033060 WO2001041750A2 (fr) 1999-12-10 2000-12-07 Nouvelles combinaisons therapeutiques de (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one et neuroleptiques destines au traitement ou a la prevention de troubles psychotiques

Publications (1)

Publication Number Publication Date
BR0016168A true BR0016168A (pt) 2002-08-20

Family

ID=23821437

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016168-3A BR0016168A (pt) 1999-12-10 2000-12-07 Combinações terapêuticas de (s)-2-(benzilaminometil)-2,3,8,9tetrahidro-7h-1,4-dioxi no[2,3 -e]indol-8-ona e neurolépticos para o tratamento ou prevenção de distúrbios psicóticos

Country Status (20)

Country Link
EP (1) EP1235570A2 (fr)
JP (1) JP5557409B2 (fr)
KR (1) KR100772854B1 (fr)
CN (1) CN1230164C (fr)
AR (1) AR026756A1 (fr)
AU (1) AU784211B2 (fr)
BR (1) BR0016168A (fr)
CA (1) CA2396351C (fr)
CZ (1) CZ20021880A3 (fr)
EA (1) EA005002B1 (fr)
HK (1) HK1045942A1 (fr)
HU (1) HUP0203309A3 (fr)
IL (2) IL149669A0 (fr)
MX (1) MXPA02005649A (fr)
NO (1) NO20022739D0 (fr)
NZ (1) NZ519381A (fr)
PL (1) PL355292A1 (fr)
TW (1) TWI222864B (fr)
WO (1) WO2001041750A2 (fr)
ZA (1) ZA200205484B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200517106A (en) 2003-10-29 2005-06-01 Wyeth Corp Sustained release pharmaceutical compositions
BRPI0608353A2 (pt) 2005-02-17 2009-12-01 Wyeth Corp derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilfundidos
BRPI0907570A2 (pt) * 2008-02-13 2019-09-24 Targacept Inc agonistas alfa7 nicotínico e antipsicóticos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2987484B2 (ja) * 1995-03-16 1999-12-06 大塚製薬 株式会社 カルボスチリル誘導体の製造方法
US5756532A (en) 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
NZ519381A (en) 2004-04-30
NO20022739L (no) 2002-06-07
KR100772854B1 (ko) 2007-11-02
CN1230164C (zh) 2005-12-07
AU784211B2 (en) 2006-02-23
CA2396351C (fr) 2009-11-10
KR20030016207A (ko) 2003-02-26
EP1235570A2 (fr) 2002-09-04
WO2001041750A3 (fr) 2002-02-14
CN1409633A (zh) 2003-04-09
PL355292A1 (en) 2004-04-05
TWI222864B (en) 2004-11-01
JP5557409B2 (ja) 2014-07-23
AU1949001A (en) 2001-06-18
EA200200656A1 (ru) 2002-12-26
HUP0203309A3 (en) 2004-12-28
HK1045942A1 (zh) 2002-12-20
HUP0203309A2 (hu) 2003-01-28
EA005002B1 (ru) 2004-10-28
AR026756A1 (es) 2003-02-26
NO20022739D0 (no) 2002-06-07
WO2001041750A2 (fr) 2001-06-14
JP2003516350A (ja) 2003-05-13
ZA200205484B (en) 2003-12-31
IL149669A0 (en) 2002-11-10
CZ20021880A3 (cs) 2002-08-14
CA2396351A1 (fr) 2001-06-14
IL149669A (en) 2006-06-11
MXPA02005649A (es) 2004-09-10

Similar Documents

Publication Publication Date Title
HK1056683A1 (en) New pharmaceutical composition
ATE231872T1 (de) Thiazolopyrimidinderivate
HUP0204399A3 (en) Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use
DK1654253T3 (da) Substituerede 3-pyrrolidinindolderivater
BR0316296A (pt) Compostos lapacone e seus métodos de uso
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
TR200200716T2 (tr) Ketiyapin granülleri
CA2284551A1 (fr) Nouvelles combinaisons therapeutiques de la mirtazapine et d'agents antipsychotiques pour le traitement ou la prophylaxie de psychoses
YU13301A (sh) Muskarinski agonisti i antagonisti
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
SE9802209D0 (sv) Novel compounds
ES2175356T3 (es) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4 fluorofenil)et il[-4- piperidinmetanol en el tratamiento de trastornos depresivos y trastornos bipolares.
SE0001916D0 (sv) Novel formulation
BR0016168A (pt) Combinações terapêuticas de (s)-2-(benzilaminometil)-2,3,8,9tetrahidro-7h-1,4-dioxi no[2,3 -e]indol-8-ona e neurolépticos para o tratamento ou prevenção de distúrbios psicóticos
DK0916670T3 (da) Pyrrolo[3,2-b]pyridiner og deres anvendelse som 5-HT1f-agonister
JO2199B1 (en) Replaced pyrrols
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
ITTO20000441A0 (it) Composizione terapeutica per la cura della psoriasi.
HUP0204258A3 (en) Use of vitamin d-derivatives for preparation of pharmaceutical compositions useful in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
DE60003074D1 (de) Fusidinsäure-derivate
WO1999019324A3 (fr) Derives de piperidine substitues
WO2003040119A8 (fr) Inhibiteurs de l'angiogenese

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10, 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]